ATLANTA, Aug. 25, 2025 /PRNewswire/ -- Vaycaychella, Inc. (OTC Pink: VAYK) ("VAYK") reported over $811K in gross revenue for the first half of 2025 in its disclosure report filed with the OTC Market last week. The company also reported a gross profit of over $237K and an operating profit...
Related Questions
How sustainable is VAYK's projected 250% YoY growth given its current cash flow and market conditions?
What are the key drivers behind the $811K revenue in the first half and how likely are they to repeat or improve in Q3/Q4?
How does VAYK's valuation and earnings multiples compare to peers in the OTC space and does the recent earnings beat justify a re-rating?